10.6084/m9.figshare.c.3697129_D4.v1
Jessica Bauer
Jessica
Bauer
Ozkan Ozden
Ozkan
Ozden
Naomi Akagi
Naomi
Akagi
Timothy Carroll
Timothy
Carroll
Daniel Principe
Daniel
Principe
Jonas Staudacher
Jonas
Staudacher
Martina Spehlmann
Martina
Spehlmann
Lars Eckmann
Lars
Eckmann
Paul Grippo
Paul
Grippo
Barbara Jung
Barbara
Jung
Additional file 2: Figure S1. of Activin and TGFβ use diverging mitogenic signaling in advanced colon cancer
Springer Nature
2015
Colon cancer
Activin
TGFβ
PI3K
Mitogenic signaling
p21
2015-10-24 05:00:00
Figure
https://springernature.figshare.com/articles/figure/Additional_file_2_Figure_S1_of_Activin_and_TGF_use_diverging_mitogenic_signaling_in_advanced_colon_cancer/4672339
ACVR2 interacts with p85 after activin treatment. FET cells were used for co-immunoprecipitation with ACVR2, TGFBR1 or TGFBR2 and Western blotted with p85. There is an induction of ACVR2/p85 association following activin treatment, however, the increase in ACVR1/p85 association was more pronounced. Neither TGFBR1 nor TGFBR2 directly associated with p85 following ligand stimulation. (EPS 3051 kb)